Cargando…
Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy
BACKGROUND: Renal cell carcinoma (RCC) is known for its ability to metastasize synchronously or metachronously to various anatomic sites. Distinguishing histologic subtypes of metastatic RCC has become increasingly important, as prognosis and therapy can differ dramatically between subtypes. We prop...
Autores principales: | Wang, Lisha, Williamson, Sean R, Wang, Mingsheng, Davidson, Darrell D, Zhang, Shaobo, Baldridge, Lee Ann, Du, Xiang, Cheng, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945615/ https://www.ncbi.nlm.nih.gov/pubmed/24568263 http://dx.doi.org/10.1186/1476-4598-13-39 |
Ejemplares similares
-
Fluorescence in situ hybridization in surgical pathology: principles and applications
por: Cheng, Liang, et al.
Publicado: (2017) -
The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype
por: Monda, Steven M., et al.
Publicado: (2023) -
Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications
por: Wang, Qiang, et al.
Publicado: (2021) -
Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell Carcinoma
por: Wang, Shichao, et al.
Publicado: (2021) -
Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma
por: Jee, ByulA, et al.
Publicado: (2022)